Tags: Drug.
Rizatriptan (trade name Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29 1998. It is a second-generation triptan.Rizatriptan is available only by prescription in Australia Finland the United States Canada and New Zealand.
